Response to "Post-marketing strategies for medicine''

被引：0
|
作者：
Goldhammer, A. [1 ]
机构：
[1] Pharmaceut Res & Manufacturers Amer, Washington, DC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷 / 01期
关键词：
D O I：
10.1038/sj.clpt.6100444
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] Post-marketing strategies for medicines
    Breckenridge, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 24 - 25
  • [2] Post-marketing drug safety in the era of genomic medicine
    Zavras, AI
    JOURNAL OF DENTAL RESEARCH, 2005, 84 (02) : 105 - 106
  • [3] POST-MARKETING SURVEILLANCE
    ROBSON, RH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) : 404 - 404
  • [4] POST-MARKETING SURVEILLANCE
    SULLMAN, SF
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1979, 72 (01) : 65 - 66
  • [5] POST-MARKETING SURVEILLANCE
    CULLITON, BJ
    WATERFALL, WK
    BRITISH MEDICAL JOURNAL, 1980, 280 (6224): : 1175 - 1176
  • [6] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [7] Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance
    Tchounga, Christelle Ange Waffo
    Sacre, Pierre-Yves
    Ravinetto, Raffaella
    Lieberman, Marya
    Ciza, Patient Hamuli
    Mballa, Rose Ngono
    Ziemons, Eric
    Hubert, Philippe
    Marini, Roland Djang'eing'a
    PLOS ONE, 2023, 18 (08):
  • [8] POST-MARKETING SURVEILLANCE OF DRUGS
    LAWSON, DH
    BRITISH MEDICAL JOURNAL, 1979, 2 (6189): : 546 - 546
  • [9] Post-marketing surveillance of buprenorphine
    Ray, R
    Pal, H
    Kumar, R
    Maulick, P
    Mangla, R
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (09) : 615 - 619
  • [10] PROBLEMS OF POST-MARKETING SURVEILLANCE
    CASTLE, WM
    NICHOLLS, JT
    DOWNIE, CC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) : 581 - 585
12345